Evidence map›Paper›PMID 35061956›Full record

ArticleHuman vaccines & immunotherapeutics2022

Status of COVID-19 vaccination around South Asia.

Mahnoor Hayat, Mohammad Uzair, Rafay Ali Syed, Muhammad Arshad, Shahid Bashir

Open access · goldAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Modern Wood-Based Materials for Sustainable Building.Materials (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Achieving COVID-19 herd immunity in Bangladesh.Public health challenges · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mahnoor HayatDepartment of Biological Sciences, Faculty of Basic & Applied Sciences, International Islamic University, Islamabad, Pakistan.
Mohammad UzairDepartment of Biological Sciences, Faculty of Basic & Applied Sciences, International Islamic University, Islamabad, Pakistan.ORCID 0000-0003-2039-0870
Rafay Ali SyedDepartment of Biological Sciences, Faculty of Basic & Applied Sciences, International Islamic University, Islamabad, Pakistan.
Muhammad ArshadDepartment of Biological Sciences, Faculty of Basic & Applied Sciences, International Islamic University, Islamabad, Pakistan.
Shahid BashirNeuroscience Center, King Fahad Specialist Hospital Dammam, Dammam, Saudi Arabia.ORCID 0000-0001-6286-6895
International Islamic University, Islamabad · PKKing Fahad Specialist Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The public health sector and the global economy are facing the challenges of the epidemic of coronavirus disease 19 (COVID-19) since December 2019. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an emerging outbreak and spreading rapidly across the globe. The COVID-19 pandemic of unprecedented proportions has devastated almost all countries and pervaded globally. However, various vaccines have been developed to achieve immunity against the virus and limit transmissibility. By 18 November 2021, 52.6% of the world population got first dose of the COVID-19 vaccine. South Asia shares 15% fully vaccinated and 22.6% partially vaccinated population in the world. The 56.5% of South Asian Association Regional Cooperation (SAARC) regions, consisting of Pakistan, Afghanistan, Bangladesh, India, Sri Lanka, Nepal, Maldives, and Bhutan, got the first shot of COVID-19 vaccine, whereas 30.5% were fully vaccinated. India has the highest percentage of the vaccinated population of about 46.5% among SAARC countries. Although South Asian countries have unstable multiple socio-economic factors, including poverty, overpopulation, low literacy about medical care and medical systems, etc., the increasing trend in vaccination status has been observed. The high percentage of health budgets of SAARC countries was utilized for purchasing COVID-19 vaccines. This report observes that South Asian countries have been significantly tackling the threats of COVID-19.

Indexed as

COVID-19COVID-19 VaccinesHumansIndiaPandemicsSARS-CoV-2VaccinationCOVID-19 VaccinesCOVAXhealth budgetimmunizationpandemicSAARCSARS-cov-2vaccines

Identifiers

PMID35061956
PMCPMC8986190
OpenAlexW4206984391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.